Article Information
History
- May 17, 2020.
Article Versions
- Version 1 (May 7, 2020 - 03:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yan Wu1,2,#,*,
- Feiran Wang3,4,#,
- Chenguang Shen3,5,#,
- Weiyu Peng3,6,#,
- Delin Li3,5,7,#,
- Cheng Zhao3,8,
- Zhaohui Li3,9,
- Shihua Li3,
- Yuhai Bi3,10,
- Yang Yang5,
- Yuhuan Gong3,10,
- Haixia Xiao7,
- Zheng Fan3,
- Shuguang Tan3,
- Guizhen Wu11,
- Wenjie Tan11,
- Xuancheng Lu12,
- Changfa Fan13,
- Qihui Wang3,
- Yingxia Liu5,
- Chen Zhang1,
- Jianxun Qi3,
- George Fu Gao3,*,
- Feng Gao7,* and
- Lei Liu5,*
- 1Department of Pathogen Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China
- 2Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China
- 3CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
- 4School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230026, China
- 5Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People’s Hospital, Shenzhen 518112, China
- 6College of Veterinary Medicine, China Agricultural University, Beijing, China
- 7Laboratory of Protein Engineering and Vaccines, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China
- 8Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China
- 9University of Chinese Academy of Sciences, Beijing 100049, China
- 10Center for Influenza Research and Early Warning, Chinese Academy of Sciences (CASCIRE), Beijing 100101, China
- 11NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
- 12Laboratory Animal Center, Chinese Center for Disease Control and Prevention, Beijing, China
- 13Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, China
- ↵*Correspondence: wuy{at}biols.ac.cn (Y.W.); gaofeng{at}tib.cas.cn (F.G.), gaof{at}im.ac.cn (G.F.G.), liulei3322{at}aliyun.com (L.L.)
↵# These authors contributed equally.
Posted May 17, 2020.
A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
